Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.
Sign Up to like & getrecommendations! Published in 2019 at "Endocrine-related cancer"
DOI: 10.1530/erc-18-0354
Abstract: Some biomarkers for functioning and non-functioning neuroendocrine neoplasms (NENs) are currently available. Despite their application in clinical practice, results should be interpreted cautiously. Considering the variable sensitivity and specificity of these parameters, there is an… read more here.
Keywords: diagnostic predictive; neoplasms current; current potential; neuroendocrine neoplasms ... See more keywords
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1071030
Abstract: At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then… read more here.
Keywords: targeting met; urologic neoplasms; treatment urologic; neoplasms current ... See more keywords